EURETINA 2024: Keynote speaker Yousif Subhi, MD, PhD, on keeping patients in focus

News
Video

Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"

At this year's European Society of Retina Specialists (EURETINA), the series of keynote lectures ended on Saturday afternoon. The final keynote address was the Ophthalmologica Lecture, delivered by Yousif Subhi, MD, PhD. The Eye Care Network spoke to him about his talk, Things that matter: An evidence-based approach to age-related macular degeneration (AMD) and central serous chorioretinopathy (CSC). In this video, you'll learn about Prof Subhi's work, what drove him to pursue this area of retina care, and the benefits of "patient-first" thinking.

Editor's note: This transcript has been lightly edited for clarity.

Yousif Subhi, MD, PhD: My name is Yousif Subhi, and I'm an associate professor of ophthalmology at University of Copenhagen in Denmark and the University of Southern Denmark and staff specialist in medical retina at Rigshospitalet in Copenhagen. I've just given the Ophthalmologica lecture here at EURETINA. It's, of course, a big privilege and honor, and I'm so happy to have been selected by the ESRS committee and the EURETINA board to give this lecture.

My lecture is on evidence-based ophthalmology. I presented my background...I did a lot of research in aging and age-related immunological changes and how that affects [the] risk of age-related macular degeneration. My mom developed cancer. She had so many questions, received so few answers, and that made me change my focus. So I focus on questions, simple clinical questions, that matters the most to the patients. And my lecture was on those patient questions in in the field of AMD and CSC.

Think patient first. So if we focus on the patients, sometimes we can do simple clinical research that really aims to answer those questions. My key takeaway is to focus on these patient experiences, and advise patients the best possible way.

EURETINA is a big conference with both phase 2 and 3 studies from the industry, with original studies from clinicians and a lot of PhD students and young ophthalmologists. One of the studies that I'm really excited about is the presentation by Dr Marianne [Guldager] Schou, who presented the impact of subretinal fluid on the refraction and how we should avoid delaying prescription glasses for patients who need it while in treatment for their AMD. I really enjoyed the [Young Retina Specialists] YOURS sessions, the young ophthalmologist sessions, here at EURETINA. They always bring in some young talents, and they do an amazing job.

Recent Videos
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
At EURETINA 2024, Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
Alexandra Miere, MD, PhD, Associate Professor of Ophthalmology, University Paris Est Créteil, France, speaks at EURETINA
Veeral S. Sheth, MD, MBA, FASRS, FACS, discussed the outcome of the Phase 1 HELIOS trial of OTX-TKI at from this year's EURETINA congress being held in Barcelona, Spain, which takes place September 19-22, 2024.
Boris Stanzel, MD, Professor of Ophthalmology, University of Bonn, Germany, at the 2024 EURETINA meeting
EURETINA 2024: Andrea Govetto, MD, PhD, speaks about macular oedema and the Ramin Tadayoni Award
Ricardo Letião Guerra, MD, MSc, FICO, speaks with Hattie Hayes of Ophthalmology Times Europe
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Related Content
© 2024 MJH Life Sciences

All rights reserved.